Long COVID Tracks With a Distinct Oral and Airway Microbiome Signature
A study from the University of Dundee has linked long COVID with marked shifts in the oral and airway microbiome, and the pattern is not confined to the mouth. In patients with the most severe persistent symptoms, the microbial profile in saliva and the respiratory tract differed sharply from that seen in people without long COVID, and those differences aligned with reduced lung function, cognitive complaints and gastrointestinal symptoms.
The signal was broad rather than isolated. Patients with extreme long COVID showed obvious microbiome changes in both the mouth and lungs, suggesting that persistent post-viral illness may involve a body-wide ecological disturbance rather than a single-organ process. In clinical terms, that matters because the syndrome itself is multisystemic: breathlessness, brain fog and gut symptoms frequently travel together, and the microbial ecosystem may be one of the biological threads linking them.
A Salivary Readout of a Multisystem Syndrome
Investigators divided 771 previously hospitalised COVID-19 patients according to the severity of their ongoing symptoms and examined the microbes present in saliva. That design places the oral cavity at the center of the analysis, but the findings extended beyond simple oral health. The microbiome differences associated with long COVID were tied to signs of impaired pulmonary function, neurocognitive symptoms such as brain fog, and gastrointestinal complaints including pain, nausea, diarrhoea and loss of appetite.
One particularly notable feature was an overabundance of bacteria that produce lactic acid. Those organisms were also associated with markers of inflammation detected in blood, adding a systemic dimension to the microbiome shift. Inflammation is not a cosmetic laboratory detail here; it provides a plausible bridge between altered microbial communities and the fatigue, dyspnoea and cognitive dysfunction patients describe months after the acute infection has passed.
Persistent inflammation can alter epithelial integrity, immune signalling and mucosal defense. In the airway, those changes may impair gas exchange or perpetuate symptoms that feel disproportionate to standard imaging or spirometry findings. In the gut, the same dysregulated immune tone may help explain why appetite, bowel habits and abdominal discomfort remain disturbed in some patients long after the original viral illness.
Why the Microbiome Has Become a Serious Candidate
Lead author Dr Daniela Alferes de Lima Headley framed the microbiome as a strong candidate in the search for long COVID biology because the condition reaches multiple organs and the microbiome helps maintain health throughout the body. That logic fits the current data. The microbiome is not just a passive bystander; it shapes immune homeostasis, mucosal barrier function and local metabolite production, all of which can influence how the body recovers after infection.
The study does not prove causation. A critical unresolved question is whether the microbiome changes were triggered by COVID-19 itself or whether they existed beforehand and increased vulnerability to long COVID after infection. Both explanations remain biologically credible. Acute SARS-CoV-2 infection can disturb microbial diversity, while a pre-existing dysbiotic state could also prime the host for prolonged inflammatory and symptom burden once the virus is cleared.
A 2023 study had already shown that COVID-19 infection can reduce the diversity of the oral microbiome, which makes the Dundee findings easier to place in context. Diversity loss often signals reduced ecological resilience. When a microbial community becomes less diverse, it can be less able to resist overgrowth by organisms that sustain inflammation or alter metabolic output in ways that affect distant organs.
Breathlessness, Brain Fog and Gut Symptoms in the Same Biological Frame
The clinical value of the Dundee data lies in the way it links a measurable biological change to the symptoms clinicians actually see. Reduced lung function, neurocognitive symptoms and gastrointestinal disturbance are often treated as separate complaints in post-COVID clinics, yet this study points toward a shared host-microbial axis. If the oral and airway microbiome is altered in parallel with systemic symptoms, then the mouth may function as an accessible window into the larger post-infectious process.
Professor James Chalmers, chair of respiratory research at the University of Dundee, argued that understanding the cause of long COVID is essential because it remains a major healthcare problem. He also pointed to a practical implication: the microbiome can potentially be modified with antibiotics, probiotics or other interventions. That statement is not a treatment recommendation, but it does reflect why this line of research has drawn attention. A modifiable biological pathway is a very different proposition from a purely descriptive syndrome.
Still, the current evidence stops short of identifying a ready-made therapy. Microbiome manipulation can be beneficial or disruptive depending on the organism targeted, the timing of intervention and the broader host context. Antibiotics may worsen dysbiosis if used indiscriminately, while probiotic strategies require careful strain selection and clinical validation before they can be translated into post-COVID care. The challenge is not simply to alter the microbiome, but to alter it in the right direction.
PHOSP-COVID and the Search for Treatable Mechanisms
The research forms part of PHOSP-COVID, a UK consortium focused on understanding and improving long-term outcomes after COVID-19. That broader framework is important because long COVID has remained difficult to pin down mechanistically despite its clear burden on patients, families and health services. Professor Raquel Duarte of the European Respiratory Society described the disabling consequences of long COVID for work, study and everyday life, and the Dundee findings fit that concern: persistent symptoms are not only subjective distress, but measurable disability with systemic consequences.
For dentistry and oral health professionals, the study is especially relevant because it reinforces the mouth as more than a local site of disease. Saliva can reflect broader inflammatory and microbial shifts, and those shifts may carry information about respiratory and systemic illness. The oral microbiome may therefore become part of a future diagnostic or stratification toolkit for post-viral syndromes, provided larger studies confirm the association and define the direction of effect.
The central limitation remains the same one that shadows much long COVID research: association is not causation. The Dundee cohort shows a strong relationship between microbiome disruption and symptom burden, but it cannot determine whether microbial change is a driver, a consequence or both. Until longitudinal studies map the microbiome before infection, during acute illness and through recovery, the causal pathway will remain unresolved. Trial data testing microbiome-targeted interventions will be needed before clinicians can know whether this biology is merely a marker of disease or a route to treatment.